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INTRODUCTION
Alcoholism is an important cause of chronic liver disease,
but only 10% to 20% of alcoholics develop cirrhosis (1).
Alcohol is oxidized initially to acetaldehyde, principally by
alcohol dehydrogenase (ADH) and cytochrome P-4502E1
(CYP2E1), and then to acetate by aldehyde dehydrogenase
(ALDH). Acetaldehyde, a highly toxic metabolite of ethanol,
has been implicated in the pathogenesis of alcoholic liver
disease (2). Theoretically, acetaldehyde accumulation in the
liver after chronic alcohol ingestion is determined by the
rates of its formation and removal, catalyzed by ADH and
CYP2E1, and ALDH, respectively. A twin study suggested
a genetic basis for individual differences in susceptibility to
alcoholic cirrhosis (3), and genetic polymorphisms of enzymes
involved in the oxidative metabolism of ethanol to acetate
are known (4-7). Therefore, these genetically determined
variations in an individual’ s ability to metabolize alcohol
might influence the prevalence of alcoholic liver disease in
alcoholics.
Persons with deficient mitochondrial ALDH (ALDH2*2)
are protected against the development of alcoholism, because
of the unpleasant symptoms (facial flushing, tachycardia, nau-
sea, etc.) after drinking (8, 9). However, it was also suggest-
ed that habitual drinkers with ALDH2 deficiency might be
at higher risk of alcohol-associated liver disease. The RsaI
and PstI polymorphisms in the 5′ -flanking region of CYP2E1
are related to the transcriptional regulation of the enzyme,
and the transcriptional activity of the c2 gene is 10 times
higher than that of the c1 gene in vitro (7). Also for ADH,
the ADH2*2 and ADH3*1 alleles encode the more active
2- and  1-ADH subunits, respectively, and these predomi-
nate in Asian populations (10-12). Therefore, these variants
of the CYP2E1 and ADH isozymes metabolize ethanol to
acetaldehyde more rapidly and may result in an increased ac-
cumulation of acetaldehyde in the liver after drinking. There-
fore, individuals with these isozymes may be either more sus-
ceptible to alcoholic cirrhosis or protected against the devel-
opment of alcoholism. However, the roles of the genetic poly-
morphisms of these enzymes, CYP2E1 and ADH, in the
development of alcoholism and alcoholic liver disease are also
controversial (9, 13-17).
Ethanol metabolism is a dynamic process involving several
enzymes, therefore, to determine the net amount of aldehyde
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Association Between Polymorphisms of Ethanol-Metabolizing Enzymes
and Susceptibility to Alcoholic Cirrhosis in a Korean Male Population
Alcohol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) and cyto-
chrome P-4502E1 (CYP2E1), and then to acetate by aldehyde dehydrogenase
(ALDH). Polymorphisms of these ethanol-metabolizing enzymes may be associ-
ated with inter-individual difference in alcohol metabolism and susceptibility to
alcoholic liver disease. We determined genotype and allele frequencies of ALDH2,
CYP2E1, ADH2, and ADH3 in male Korean patients with alcoholic cirrhosis (n=56),
alcoholics without evidence of liver disease (n=52), and nondrinkers (n=64) by
using PCR or PCR-directed mutagenesis followed by restriction enzyme diges-
tion. The prevalences of heterozygous ALDH2*1/*2 plus homozygous ALDH2*2/
*2 in patients with alcoholic cirrhosis (7.1%) and alcoholics without evidence of
liver disease (3.8%) were significantly lower than that in nondrinkers (45.3%). The
c2 allele frequencies of the CYP2E1 in alcoholic cirrhosis, alcoholics without evi-
dence of liver disease, and nondrinkers were 0.21, 0.20, and 0.20, respectively.
Allele frequencies of ADH2*2 in the three groups were 0.78, 0.74, and 0.77 and
those of ADH3*1 were 0.94, 0.98, and 0.95. Therefore, we confirmed the obser-
vation that the ALDH2*2 gene protects against the development of alcoholism.
However, the development of cirrhosis in Korean alcoholic patients was not as-
sociated with polymorphisms of ethanol-metabolizing enzymes.
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produced, it is necessary to simultaneously analyze the poly-
morphisms of these ethanol-metabolizing enzymes. There-
fore, we analyzed the genetic polymorphisms of all these
enzymes simultaneously to assess whether they affect pre-
disposition to alcoholism and/or alcoholic cirrhosis suscepti-
bility.
MATERIALS AND METHODS
Subjects
Blood samples were obtained from 56 patients with alco-
holic cirrhosis, 52 alcoholics without evidence of liver disease,
and 64 nondrinkers. Because there is evidence that women
have increased susceptibility to alcoholic cirrhosis (18), females
were excluded from the study. Patients with alcoholic cir-
rhosis (alcoholic cirrhosis group) enrolled into this study con-
sumed more than 80 g of ethanol per day for more than 10
yr and had clinical evidences of portal hypertension such as
esophageal varices, ascites, or hepatic encephalopathy. All
the alcoholic cirrhotic patients were negative for the hepatitis
B surface antigen and the antibody to hepatitis C virus by
the radioimmunoassay (Abbott Laboratories, North Chicago,
IL) and the second-generation enzyme immunoassay (Abbott
Laboratories), respectively. Alcoholic patients without clini-
cal evidence of liver disease (alcoholics group) also consumed
more than 80 g of ethanol per day for more than 10 yr, and
had normal liver function test values without clinical or radi-
ological (ultrasonography or CT) evidence of liver disease.
Age-matched healthy males who drank less than 80 g per
week were arbitrarily defined as nondrinkers.
There was no significant difference in age, total and mean
daily amount of ethanol intake, and duration of drinking be-
tween the alcoholic cirrhosis group and the alcoholics group
(Table 1).
Determination of ALDH2, CYP2E1, ADH2, and ADH3
genotypes
The buffy coat was separated from 10 mL of anti-coagu-
lated blood containing acid citrated dextrose solution, and
the DNA of white blood cells was extracted by the method
of Blin et al. (19).
ALDH2 genotypes were determined according to Chao
et al. (9) using a PCR-directed mutagenesis method with
some modifications. Primers YC1 (5ꆢ CCACACTCACAGT-
TTTGAATT3ꆢ ) and YC2 (5ꆢ GGCTACAAGAATTCGGG-
GAGT3ꆢ ) were used to amplify the ALDH2 gene. After am-
plification, the genotypes were determined by EcoRI restric-
tion fragment length polymorphisms.
The RsaI and PstI polymorphisms of the CYP2E1 gene
were determined according to Hayashi et al. (7), using primers
J8 (5ꆢ TTCATTCTGTCTTCTAACTGG3ꆢ ) and J9 (5ꆢ CCA
GTCGAGTCTACATTGTCA3ꆢ ). The amplified products
were digested with RsaI or PstI.
ADH2 and ADH3 genotypes were determined according
to Groppi et al. (20) with some modifications. For detection
of the ADH2*2 allele, ADH2 exon 3 was amplified with
primers 303 (5ꆢ ATTCTGTAGATGGTGGCTGT3ꆢ ) and
247 (5ꆢ GAAGGGGGGTCACCAGGTTG3ꆢ ), and the pro-
ducts were digested with MaeIII. For identification of the
ADH2*3 allele, ADH2 exon 9 was amplified with primers
HE39 (5ꆢ TGGACTCTCACAACAAGCATGT3ꆢ ) (21) and
290 (5ꆢ TTTCTTTGGAAAGCCCCCAT3ꆢ ), and then PCR-
directed mutagenesis using primers 352 (5ꆢ TCTTTCCTAT
TGCAGTAGC3ꆢ ) and 290 was performed with 1/500 of the
first amplification mixture as a template. The second amplifi-
cation products were digested with AluI. For determination
of the ADH3 genotypes, primers 321 (5ꆢ GCTTTAAGAG-
TAAATATTCTGTC-CCC3ꆢ ) and 351 (5ꆢ AATCTACCTC-
TTTCCGAAGC3ꆢ ) were used to amplify the ADH3 loci, and
then the amplified products were digested with SspI.
Group No. of cases Age (yr)
Alcohol consumption
Total (kg) Daily (g) Duration (yr)
Alcoholic cirrhosis 56 52.2±9.3 1357.4±1196.5 165.6±91.8 22.7±9.9
Alcoholics 52 51.7±10.1 1215.0±807.1 152.8±99.6 22.8±9.8
Nondrinkers 64 50.4±7.5 31.8±26.5 4.1±2.8 18.8±12.5
Table 1. Comparison of age and alcohol consumption
Results are expressed as means±SD, No., Number
Group
Allele frequency Genotype
ALDH2*2/*2 ALDH2*1/*2 ALDH2*1/*1 ALDH2*1 ALDH2*2
Alcoholic cirrhosis (n=56) 52 (92.9%) 4 (7.1%) 0 (0%) 0.96 0.04*
Alcoholics (n=52) 50 (96.2%) 2 (3.8%) 0 (0%) 0.98 0.02*
Nondrinkers (n=64) 35 (54.7%) 25 (39.1%) 4 (6.2%) 0.74 0.26
Table 2. Genotype and allele frequencies of ALDH2
*p=0.001 compared with nondrinkers. ALDH2, aldehyde dehydrogenase 2Ethanol-Metabolizing Enzymes and Alcoholic Cirrhosis 747
Statistical analysis
For group comparison,  2 test or Student’ s t-test was used.
A p value of <.05 was considered statistically significant. 
RESULTS
Genetic polymorphism of ALDH2
Table 2 shows the genotype and allele frequencies of ALD
H2 in each group. Whereas the genotype frequency of het-
erozygous ALDH2*1/*2 plus homozygous ALDH 2*2/*2
was 45.3% in nondrinkers, they were 3.8% and 7.1% in the
alcoholics group and the alcoholic cirrhosis group, respec-
tively (p=0.001). The allele frequencies of ALDH2*2 were
0.04 in the alcoholic cirrhosis group, 0.02 in the alcoholics
group, and 0.26 in nondrinkers.
Genetic polymorphism of CYP2E1 with RsaI/PstI
There was no difference in genotype distribution and allele
frequencies among the three groups. The allele frequencies
of c2 gene were 0.21 in the alcoholic cirrhosis group, 0.20
in the alcoholics group, and 0.20 in nondrinkers (Table 3).
Genetic polymorphism of ADH2
The allele frequencies of ADH2*2 were 0.78 in the alco-
holic cirrhosis group, 0.74 in the alcoholics group, and 0.77
in nondrinkers. There was no significant difference in geno-
type distribution and allele frequencies of ADH2*2 gene
among the three groups (Table 4). Neither homozygote nor
heterozygote for ADH2*3 allele was found in the Korean
population.
Genetic polymorphism of ADH3
The allele frequencies of ADH3*2 were 0.06 in the alco-
holic cirrhosis group, 0.02 in the alcoholics group, and 0.05
in nondrinkers. There was no significant difference in geno-
type distribution and allele frequencies of ADH3*2 gene
among the three groups (Table 5).
Genotype and allele frequencies of CYP2E1 in sub-
jects with ADH2*2/*2, ADH3*1/*1, and ALDH2*1/*1
We analyzed the genotype and allele frequencies of CYP
2E1 in subjects with ADH2*2/*2, ADH3*1/*1, and ALD
H2*1/*1 to exclude the possible influence of ethanol-metab-
olizing enzymes other than CYP2E1. There was no signifi-
cant difference among the three groups (Table 6).
Group
Allele frequency Genotype
ALDH2*2/*2 ALDH2*1/*2 ALDH2*1/*1 ALDH2*1 ALDH2*2
Alcoholic cirrhosis (n=56) 7 (12.5%) 11 (19.6%) 38 (67.9%) 0.22 0.78
Alcoholics (n=52) 3 (5.8%) 21 (40.4%) 28 (53.8%) 0.26 0.74
Nondrinkers (n=64) 6 (9.4%) 18 (28.1%) 40 (62.5%) 0.23 0.77
Table 4. Genotype and allele frequencies of ADH2
ADH2, alcohol dehydrogenase 2
Group
Allele frequency Genotype
ADH3*2/*2 ADH3*1/*2 ADH3*1/*1 ADH3*1 ADH3*2
Alcoholic cirrhosis (n=56) 50 (89.3%) 5 (8.9%) 1 (1.8%) 0.94 0.06
Alcoholics (n=52) 50 (96.2%) 2 (3.8%) 0 (0%) 0.98 0.02
Nondrinkers (n=64) 57 (89.1%) 7 (10.9%) 0 (0%) 0.95 0.05
Table 5. Genotype and allele frequencies of ADH3
ADH3, alcohol dehydrogenase 3
Group
Allele frequency Genotype
C (c2/c2) B (c1/c2) A (c1/c1) c1 c2
Alcoholic cirrhosis (n=56) 34 (60.7%) 21 (37.5%) 1 (1.8%) 0.79 0.21
Alcoholics (n=52) 32 (61.5%) 19 (36.6%) 1 (1.9%) 0.80 0.20
Nondrinkers (n=64) 41 (64.0%) 22 (34.4%) 1 (1.6%) 0.80 0.20
Table 3. Genotype and allele frequencies of CYP2E1
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Genotype and allele frequencies of ADH2 in subjects
with ADH3*1/*1, CYP2E1 c1/c1, and ALDH2*1/*1 
Table 7 shows the genotype and allele frequencies of ADH2
in subjects with ADH3*1/*1, CYP2E1 c1/c1, and ALDH2
*1/*1. Still, there was no significant difference among groups. 
DISCUSSION
In the present study, we confirmed previous observations
that the ALDH2*2 gene protects against the development
of alcoholism (8, 9). However, we could not prove the hy-
pothesis that habitual drinkers with ALDH2 deficiency may
be at higher risk of alcoholic liver disease (22). This may be
due to the relatively small sample size in our study. However,
considering the low prevalence of ALDH2 deficiency among
alcoholics as a whole, it is unlikely that the genotypes of
ALDH2 are the main determinant of alcoholic liver disease.
The effect of the c2 allele on the development of alcoholic
liver disease is quite controversial (15-17). We could not
confirm the previous observation by Tsutsumi et al. (15) that
persons with the c2 allele are prone to the development of
advanced alcoholic liver disease. These findings are consis-
tent with the report of Chao et al. (17) in the Chinese popu-
lation. Moreover, we found that the genotype and allele fre-
quencies of CYP2E1 in subjects with ADH2*2/*2, ADH3
*1/*1, and ALDH2*1/*1, analyzed to exclude the possible
influence of ethanol-metabolizing enzymes other than CYP
2E1, showed no significant difference among patients with
alcoholic cirrhosis, alcoholics without evidence of liver dis-
ease, and healthy nondrinkers. The increased transcriptional
activity of the c2 gene in vitro (7) may not reflect the activi-
ty in vivo. CYP2E1 phenotyping can be accurately assessed
using chlorzoxazone metabolism in vivo (23). In studies using
chlorzoxazone metabolism as a CYP2E1 probe, subjects het-
erozygous for the c2 allele did not show any difference in
CYP2E1 activity at the basal level (23, 24). Furthermore,
Lucas et al. (25) reported that patients with the mutated
genotype are less inducible than those homozygous for the
c1 allele after ethanol induction. So far, there is no direct
evidence that allelic forms of the CYP2E1 gene are related
to the metabolic phenotypes.
Roles of polymorphisms of the ADH enzymes in the devel-
opment of alcoholism are also controversial (9, 13, 14). Al-
though the  22 and  11 isozymes of ADH have 40- and
2.5-fold higher Vmax than do the  11 and  22   isozymes
in vitro (26), respectively, their effects on ethanol metabolism
in vivo are not well-defined. Actually, no differences in the
rate of alcohol elimination have been reported between in-
dividuals with the ADH2*1 and ADH2*2 (27). In the pre-
sent study, we could not confirm the previous observation
by Chao et al. that ADH2*2 and ADH3*1 alleles protect
against the development of alcoholism in a Chinese popula-
tion (9). This discrepancy may not have resulted from the
small sample size, because the sample size needed for 90%
certainty of detecting a reduction in allele frequency of
ADH2*2 from 0.73 (in controls) to 0.51 (in alcoholics as a
whole) with p<.05, as observed in the study by Chao et al.
(9), is about 100 alleles (50 persons) in each group (i.e. con-
trol group and alcoholics group). The discrepancy between
the Korean and Chinese population may be attributed to
the different cultural background for drinking. In a cross-
cultural study on drinking behavior between Koreans and
Chinese, it was reported that traditionally Korean people
usually encourage each other to drink in quantity, whereas
controlled drinking behavior is more common in Chinese
(28). Therefore, many Korean people have to drink against
their wills to maintain their social relationships if their adverse
symptoms are not as severe as in persons with ALDH defi-
Group
Allele frequency Genotype
C (c2/c2) B (c1/c2) A (c1/c1) c1 c2
Alcoholic cirrhosis (n=35) 21 (60.0%) 13 (37.1%) 1 (2.9%) 0.79 0.21
Alcoholics (n=26) 18 (69.2%) 7 (26.9%) 1 (3.9%) 0.83 0.17
Nondrinkers (n=21) 11 (52.4%) 10 (47.6%) 0 (0%) 0.76 0.24
Table 6. Genotype and allele frequencies of CYP2E1 in subjects with ADH2*2/*2, ADH3*1/*1, and ALDH2*1/*1
ADH2, alcohol dehydrogenase 2; ADH3, alcohol dehydrogenase 3; ALDH2, aldehyde dehydrogenase 2; CYP2E1, cytochrome P-4502E1
Group
Allele frequency Genotype
ALDH2*2/*2 ALDH2*1/*2 ALDH2*1/*1 ALDH2*1 ALDH2*2
Alcoholic cirrhosis (n=28) 2 (7.1%) 5 (17.9%) 21 (75.0%) 0.16 0.84
Alcoholics (n=29) 1 (3.4%) 10 (34.5%) 18 (62.1%) 0.21 0.79
Nondrinkers (n=18) 1 (5.6%) 6 (33.3%) 11 (61.1%) 0.22 0.78
Table 7. Genotype and allele frequencies of ADH2 in subjects with ADH3*1/*1, CYP2E1 c1/c1, and ALDH2*1/*1
ADH2, alcohol dehydrogenase 2; ADH3, alcohol dehydrogenase 3; ALDH2, aldehyde dehydrogenase 2; CYP2E1, cytochrome P-4502E1Ethanol-Metabolizing Enzymes and Alcoholic Cirrhosis 749
ciency. However, a recent study (29) that analyzed a large
European sample (876 samples) also showed that the ADH2
*2 allele decreases the risk for alcoholism (0.038, nonalco-
holics; 0.013, alcoholics). Therefore, we could not complete-
ly exclude the possibility that the ADH2*2 allele protects
from the development of alcoholism because our sample size
is relatively small compared with that of the European study.
Because results are quite conflicting whether polymor-
phisms of ethanol-metabolizing enzymes are related with
the risk of alcohol-related cirrhosis, a search for alternative
candidate genes has been made recently. Because endotox-
emia has been suggested to play an important role in the
development of alcoholic liver disease, genes regulating cyto-
kine expression have been studied as alternative candidate
genes. To date, polymorphisms in the tumor necrosis factor
promoter and the interleukin-1 receptor antagonist gene
have been reported to be associated with the development
of alcoholic liver disease (30, 31). Further studies are needed
to confirm these findings. 
In conclusion, we confirmed the observation that the AL
DH2*2gene protects against the development of alcoholism.
However, the development of cirrhosis in male Korean alco-
holic patients was not associated with polymorphisms of the
ethanol-metabolizing enzymes (ADH2, ADH3, CYP2E1,
and ALDH2). In particular, the lack of association between
ADH polymorphisms and the development of alcoholism
might be due to the unique drinking culture in Korea.
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